Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Poliomyelitis Vaccine (Oral) Sabin Strain
Active Ingredients: Polio virus type 1 1,000,000CCID50
Polio virus type 2 100,000CCID50
Polio virus type 3 316,227CCID50
Dosage Form: Oral suspension
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: GlaxoSmithKline Biologicals SA, Rixensart, Belgium
Dated this 5th day of August 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).